Senti Biosciences, Inc. (SNTI)
NASDAQ: SNTI · Real-Time Price · USD
2.150
-0.050 (-2.29%)
Nov 8, 2024, 10:46 AM EST - Market open

Senti Biosciences Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021 FY 2020 FY 2019
Period Ending
Jun '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
Revenue
0.342.564.292.760.570.09
Revenue Growth (YoY)
-91.65%-40.25%55.23%387.81%565.88%-
Cost of Revenue
36.1432.1528.1521.9615.9614.52
Gross Profit
-35.81-29.59-23.86-19.2-15.39-14.44
Selling, General & Admin
25.0934.8538.2321.259.37.34
Operating Expenses
25.0934.8538.2321.259.37.34
Operating Income
-60.9-64.44-62.08-40.45-24.69-21.78
Interest & Investment Income
1.582.861.70.010.090.67
Other Non Operating Income (Expenses)
5.853.3-0.03-0.12-0.05-0.04
EBT Excluding Unusual Items
-53.48-58.28-60.42-40.56-24.65-21.15
Asset Writedown
-25.96-25.96--0.02-0.24-0.01
Other Unusual Items
0.820.8310.75-14.745.03-
Pretax Income
-78.62-83.41-49.67-55.32-19.86-21.16
Earnings From Continuing Operations
-78.62-83.41-49.67-55.32-19.86-21.16
Earnings From Discontinued Operations
21.6612.35-8.55---
Net Income
-56.95-71.06-58.21-55.32-19.86-21.16
Net Income to Common
-56.95-71.06-58.21-55.32-19.86-21.16
Shares Outstanding (Basic)
543011
Shares Outstanding (Diluted)
543011
Shares Change (YoY)
2.53%69.94%796.58%-78.99%2.03%-
EPS (Basic)
-12.62-16.01-22.29-189.95-14.33-15.57
EPS (Diluted)
-12.62-16.01-22.29-189.95-14.33-15.57
Free Cash Flow
-44.32-64.43-76.27-40.18-25.33-20.37
Free Cash Flow Per Share
-9.82-14.52-29.21-137.96-18.28-15.00
Operating Margin
-18017.46%-2516.28%-1448.53%-1464.90%-4362.90%-25625.88%
Profit Margin
-16850.00%-2774.62%-1358.14%-2003.59%-3509.19%-24890.59%
Free Cash Flow Margin
-13112.43%-2515.93%-1779.51%-1455.20%-4475.97%-23969.41%
EBITDA
-56.6-60.88-60.69-39.68-24.13-21.36
D&A For EBITDA
4.33.561.40.770.560.43
EBIT
-60.9-64.44-62.08-40.45-24.69-21.78
Revenue as Reported
0.342.564.292.760.570.09
Source: S&P Capital IQ. Standard template. Financial Sources.